|
"et al"的相關文件
顯示項目 26-35 / 339 (共34頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2022-09-20T01:23:54Z |
Target-Adverse Events and Fear of Cancer Progression, Anxiety, and Depression in Patients with Advanced Non-Small Cell Lung Cancer
|
Yu, C.C.; CHIA-YU CHU; Lai, Y.H.; Chan, J.C.; et al., |
| 臺大學術典藏 |
2022-09-20T01:16:04Z |
Economic impact of abrocitinib monotherapy and combination therapy in patients with moderate-to-severe atopic dermatitis: Results from JADE MONO-2 and JADE COMPARE
|
Gooderham, Melinda J; CHIA-YU CHU; Rojo, Ricardo; Valdez, Hernan; Biswas, Pinaki; Cameron, Michael C; et al., |
| 臺大學術典藏 |
2022-09-20T01:07:41Z |
Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis: Analysis of Follow-up Data From the Measure Up 1 and Measure Up 2 Randomized Clinical Trials
|
Simpson, Eric L; Papp, Kim A; Blauvelt, Andrew; CHIA-YU CHU; Hong, H Chih-Ho; Katoh, Norito; et al., |
| 臺大學術典藏 |
2022-09-20T00:48:42Z |
Comparing abrocitinib and dupilumab in the treatment of atopic dermatitis: a plain language summary
|
Bieber, Thomas; Simpson, Eric L; Silverberg, Jonathan I; Thaçi, Diamant; Paul, Carle; Pink, Andrew E; Kataoka, Yoko; CHIA-YU CHU; DiBonaventura, Marco; et al., |
| 臺大學術典藏 |
2022-09-19T08:50:00Z |
IgE-neutralizing UB-221 mAb, distinct from omalizumab and ligelizumab, exhibits CD23-mediated IgE downregulation and relieves urticaria symptoms
|
Kuo, Be-Sheng; Li, Chao-Hung; Chen, Jiun-Bo; Shiung, Yu-Yu; CHIA-YU CHU; Lee, Chih-Hung; Liu, Yaw-Jen; et al., |
| 臺大學術典藏 |
2022-09-19T08:47:40Z |
Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one-year extension study
|
Maurer, Marcus; Giménez-Arnau, Ana; Bernstein, Jonathan A; CHIA-YU CHU; Danilycheva, Inna; Hide, Michihiro; et al., |
| 臺大學術典藏 |
2022-09-19T08:32:28Z |
The Value of Heart Rhythm Complexity in Identifying High-Risk Pulmonary Hypertension Patients
|
Tang, S.-Y.; Ma H.-P.; Hung, C.-S.; Kuo, P.-H.; Lin, C.; Lo, M.-T.; HSAO-HSUN HSU; et al., |
| 臺大學術典藏 |
2022-09-19T08:24:24Z |
Vicryl Mesh Coverage Reduced Recurrence After Bullectomy for Primary Spontaneous Pneumothorax
|
HSAO-HSUN HSU; Liu, Yun-Hen; Chen, Hsuan-Yu; Chen, Pei-Hsing; Chen, Ke-Cheng; Hsieh, Ming-Ju; Lin, Mong-Wei; Kuo, Shuenn-Wen; Huang, Pei-Ming; et al., |
| 國家衛生研究院 |
2022-08-22 |
Whole genome association study of the plasma metabolome identifies metabolites linked to cardiometabolic disease in black individuals
|
Tahir, UA;Katz, DH;Avila-Pachecho, J;Bick, AG;Pampana, A;Robbins, JM;Yu, Z;Chen, ZZ;Benson, MD;Cruz, DE;Ngo, D;Deng, S;Shi, X;Zheng, S;Eisman, AS;Farrell, L;Hall, ME;Correa, A;Tracy, RP;Durda, P;Taylor, KD;Liu, Y;Johnson, WC;Guo, X;Yao, J;Chen, YDI;Manichaikul, AW;Ruberg, FL;Blaner, WS;Jain, D;Bouchard, C;Sarzynski, MA;Rich, SS;Rotter, JI;Wang, TJ;Wilson, JG;Clish, CB;Natarajan, P;Gerszten, RE;Abe, N;Abecasis, G;Aguet, F;Albert, C;Almasy, L;Alonso, A;Ament, S;Anderson, P;Anugu, P;Applebaum-Bowden, D;Ardlie, K;Arking, D;Arnett, DK;Ashley-Koch, A;Aslibekyan, S;Assimes, T;Auer, P;Avramopoulos, D;Ayas, N;Balasubramanian, A;Barnard, J;Barnes, K;Barr, RG;Barron-Casella, E;Barwick, L;Beaty, T;Beck, G;Becker, D;Becker, L;Beer, R;Beitelshees, A;Benjamin, E;Benos, T;Bezerra, M;Bielak, L;Bis, J;Blackwell, T;Blangero, J;Blue, N;Boerwinkle, E;Bowden, DW;Bowler, R;Brody, J;Broeckel, U;Broome, J;Brown, D;Bunting, K;Burchard, E;Bustamante, C;Buth, E;Cade, B;Cardwell, J;Carey, V;Carrier, J;Carson, A;Carty, C;Casaburi, R;Romero, JPC;Casella, J;Castaldi, P;Chaffin, M, .; et al. |
| 臺大學術典藏 |
2022-08-12T06:38:49Z |
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
|
Martin, Miguel; Holmes, Frankie A; Ejlertsen, Bent; Delaloge, Suzette; Moy, Beverly; Iwata, Hiroji; von Minckwitz, Gunter; Chia, Stephen K L; Mansi, Janine; Barrios, Carlos H; Gnant, Michael; KING-JEN CHANG; et al., |
顯示項目 26-35 / 339 (共34頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
|
